Jyotika Rajawat
Lucknow, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Poly(ADP-ribose) polymerase1 (PARP1) and PARP inhibitors: New frontiers in cervical cancer.
Journal: Biochemical and biophysical research communications
Published: September 03, 2024
Targeted inhibition of MASTL kinase activity induces apoptosis in breast cancer.
Journal: Life sciences
Published: May 24, 2023
Enhanced therapeutic efficacy of Piperlongumine for cancer treatment using nano-liposomes mediated delivery.
Journal: International journal of pharmaceutics
Published: March 24, 2023
PARP inhibitor olaparib induced differential protein expression in cervical cancer cells.
Journal: Journal of proteomics
Published: November 09, 2022
Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation.
Journal: Medical oncology (Northwood, London, England)
Published: January 12, 2022
WITHDRAWN: Therapeutic Targeted Approaches for Covid-19 Treatment
Journal: Current pharmaceutical biotechnology
Published: August 31, 2021
Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor.
Journal: Journal of biomolecular structure & dynamics
Published: May 05, 2021
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.
Journal: International journal of molecular sciences
Published: February 25, 2021
Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis.
Journal: Current drug targets
Published: September 27, 2020
Present and future of artificial intelligence in dentistry.
Journal: Journal of oral biology and craniofacial research
Published: June 03, 2020
Poly(ADP-Ribose) polymerase 1: a therapeutic hope in gynecologic cancers.
Journal: Frontiers in bioscience (Scholar edition)
Published: April 15, 2017
Last Updated: 09/26/2026